Navigating the school year with type 1 diabetes: A call to support and action
A T1D dad and physician's POV about the start of a new school year.
Powering research breakthroughs
We invest in the most promising research to turn ideas into life-changing therapies and lead the way to cures.
Diagnosed days before hosting 100K country music fans
Sarah Trahern is CEO of the Country Music Association (CMA). Read her T1D story.
Top Type 1 Diabetes Advances of Fiscal Year 2023
Breakthrough T1D highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.
A Bittersweet Goodbye for Breakthrough T1D Champion Cynthia Rice
JDRF’s Chief Mission Strategy Officer will leave behind quite a legacy once she steps down from her role at Breakthrough…
FDA Approved! Abbott FreeStyle Libre® 3 Continuous Glucose Monitor, Ages 4+
The FDA cleared the FreeStyle Libre 3 continuous glucose monitor (CGM) for children and adults ages 4 and up with diabetes
Smart Insulin Pen/Smart Cap Bridge Technology Gap for MDI
People living with T1D who prefer multiple daily injections (MDI) of insulin now have two high-tech management options: An insulin…
Abbott FreeStyle Libre 2 iOS App Receives FDA Approval
On August 2, 2021, Abbott announced the FreeStyle Libre 2 iOS app received approval from the FDA for adults and…
Bigfoot Is Real—and Received FDA Clearance
The Bigfoot Unity™ Diabetes Management by Bigfoot Biomedical received FDA clearance for individuals 12 and older.
Tandem Diabetes Care in the Real World
Two leaders from Tandem Diabetes Care share real-world outcomes from Tandem insulin pump users, other practical insights.
